Market Cap 43.25M
Revenue (ttm) 0.00
Net Income (ttm) -37.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.81
Volume 297,000
Avg Vol 537,356
Day's Range N/A - N/A
Shares Out 47.03M
Stochastic %K 21%
Beta 1.11
Analysts Strong Sell
Price Target $7.50

Company Profile

PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, developing a pipeline of targeted cancer immunotherapies. The company's lead product candidate is Versamune HPV, which is in phase II clinical trial for the treatment of head and neck, cervical, anal, vaginal, vulvar, and penile cancers. It also develops various product candidates, which are in preclinical trials, including PDS0102, an investigational immunotherapy utilizing tumor-associated and immunologically active T c...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 208 3343
Address:
303A College Road East, Princeton, United States
Mr_Charlie
Mr_Charlie Oct. 25 at 7:27 AM
$PDSB it seems they are going to reverse split it. There 's no other possible outcome here. What a bad investment I made!
0 · Reply
Llamalamb2921
Llamalamb2921 Oct. 24 at 6:42 PM
$PDSB Frank, Still waiting on an update from our phase 3 trial. Are we throwing away money opening more sites, or do you have plans to actually complete this trial?
0 · Reply
Kosmokrat
Kosmokrat Oct. 24 at 4:49 PM
$PDSB I was watching Adverum for quite a while, they went low on cash, but had a promising phase 3 trial running. Today they were bought by Eli Lilly. I guess the same will happen to $PDSB. I asked Microsoft Copilot to assess the value of $PDSB 's pipeline, and this was the result: Estimated Pipeline Value (Indicative Only) While no formal valuation has been published, biotech analysts often use risk-adjusted net present value (rNPV) models. Based on comparable immunotherapy platforms and Fast Track assets, rough estimates suggest: PDS0101 alone could be worth $150M$300M if Phase 3 confirms survival benefit and leads to FDA approval The entire pipeline might be valued at $250M$500M in a favorable scenario, assuming partnerships or licensing deals.
0 · Reply
Ontherag
Ontherag Oct. 23 at 11:54 PM
$PDSB I don’t think they are looking for an offering. Just gonna sell it for whatever price they can get. Similar thing happened INZY, went low on cash, went down to $1 and sold for 4. Who knows tho, hopefully something happens one way or another.
2 · Reply
Mr_Charlie
Mr_Charlie Oct. 23 at 5:26 PM
$PDSB the stock price movement for a company that had a very good ph2 clinical trial is completely out of context. I can only assume they are going bankrupt. Just yesterday another biotech got results for their ph2 and price went up 150%. This is shocking company.
1 · Reply
Whyleb111
Whyleb111 Oct. 23 at 4:44 PM
$PDSB please just put us out of our misery.
1 · Reply
Mr_Charlie
Mr_Charlie Oct. 23 at 4:03 PM
$PDSB here we go to the 0.80's.
0 · Reply
EddieH2020
EddieH2020 Oct. 23 at 3:18 PM
$PDSB Will be curious what update is during Q3 call in a few weeks
1 · Reply
dvice2
dvice2 Oct. 22 at 9:58 PM
$PDSB time to come out of hiding and give information to your shareholders, Frank
3 · Reply
EddieH2020
EddieH2020 Oct. 22 at 7:56 PM
$PDSB I told you to buy SLS - let’s check back in 3-4 weeks who is higher
1 · Reply
Latest News on PDSB
PDS Biotech Leadership to Participate in March Conferences

Mar 11, 2025, 8:00 AM EDT - 8 months ago

PDS Biotech Leadership to Participate in March Conferences


PDS Biotechnology: Continuing The Holding Pattern

Sep 23, 2024, 10:39 AM EDT - 1 year ago

PDS Biotechnology: Continuing The Holding Pattern


PDS Biotechnology Announces Details of Virtual KOL Event

May 3, 2024, 8:00 AM EDT - 1 year ago

PDS Biotechnology Announces Details of Virtual KOL Event


Mr_Charlie
Mr_Charlie Oct. 25 at 7:27 AM
$PDSB it seems they are going to reverse split it. There 's no other possible outcome here. What a bad investment I made!
0 · Reply
Llamalamb2921
Llamalamb2921 Oct. 24 at 6:42 PM
$PDSB Frank, Still waiting on an update from our phase 3 trial. Are we throwing away money opening more sites, or do you have plans to actually complete this trial?
0 · Reply
Kosmokrat
Kosmokrat Oct. 24 at 4:49 PM
$PDSB I was watching Adverum for quite a while, they went low on cash, but had a promising phase 3 trial running. Today they were bought by Eli Lilly. I guess the same will happen to $PDSB. I asked Microsoft Copilot to assess the value of $PDSB 's pipeline, and this was the result: Estimated Pipeline Value (Indicative Only) While no formal valuation has been published, biotech analysts often use risk-adjusted net present value (rNPV) models. Based on comparable immunotherapy platforms and Fast Track assets, rough estimates suggest: PDS0101 alone could be worth $150M$300M if Phase 3 confirms survival benefit and leads to FDA approval The entire pipeline might be valued at $250M$500M in a favorable scenario, assuming partnerships or licensing deals.
0 · Reply
Ontherag
Ontherag Oct. 23 at 11:54 PM
$PDSB I don’t think they are looking for an offering. Just gonna sell it for whatever price they can get. Similar thing happened INZY, went low on cash, went down to $1 and sold for 4. Who knows tho, hopefully something happens one way or another.
2 · Reply
Mr_Charlie
Mr_Charlie Oct. 23 at 5:26 PM
$PDSB the stock price movement for a company that had a very good ph2 clinical trial is completely out of context. I can only assume they are going bankrupt. Just yesterday another biotech got results for their ph2 and price went up 150%. This is shocking company.
1 · Reply
Whyleb111
Whyleb111 Oct. 23 at 4:44 PM
$PDSB please just put us out of our misery.
1 · Reply
Mr_Charlie
Mr_Charlie Oct. 23 at 4:03 PM
$PDSB here we go to the 0.80's.
0 · Reply
EddieH2020
EddieH2020 Oct. 23 at 3:18 PM
$PDSB Will be curious what update is during Q3 call in a few weeks
1 · Reply
dvice2
dvice2 Oct. 22 at 9:58 PM
$PDSB time to come out of hiding and give information to your shareholders, Frank
3 · Reply
EddieH2020
EddieH2020 Oct. 22 at 7:56 PM
$PDSB I told you to buy SLS - let’s check back in 3-4 weeks who is higher
1 · Reply
Mr_Charlie
Mr_Charlie Oct. 22 at 11:02 AM
$PDSB nobody trust this stock. Management is unable to provide assurance of success. I won't be surprise if it continues to drop.
3 · Reply
alphabetsop
alphabetsop Oct. 21 at 11:58 PM
$PDSB anyone see the nugget trading guy on X announced he entered the stock . of course, not to any fanfare as this poster seems like someone with an exaggerated sense of self-importance to dangle and ultimately confirm entry for the entire world..who truly cares. better be some news in next few weeks in advance of Q3 earnings as new cash levels will be interesting
1 · Reply
Stockman824
Stockman824 Oct. 21 at 12:57 PM
$PDSB sold a couple thousand MONTHS ago for tax write off and lower cost average. Turned that into shares of $VKTX but yesterday bought a couple thousand back of PDSB at .98 cents hoping we turn a f ing corner and get some non dilutive financing. 🤞 the data is as good as you can get but management has truly dropped the ball in monumental ways. New management would certainly help the SP. I’m also going to have an extra 15 grand in about 2-3 weeks that I will put into the market. Any ideas for me to start researching? Thanks in advance
1 · Reply
Ontherag
Ontherag Oct. 20 at 8:37 PM
$PDSB Comon Frank, sell this biatch
2 · Reply
Kaann
Kaann Oct. 20 at 6:45 AM
$PDSB will be banger soon 💥
1 · Reply
alphabetsop
alphabetsop Oct. 18 at 5:33 PM
$PDSB so the idea running is that they have a deal in place but are not announcing it? So are they intending to avoid Nasdaq's disclosure rules on materials events and also wanting to make certain we are trading at a nickle first. Is that what is being referred to as strategic timing? If they had a deal it would have been announced two years ago.
2 · Reply
EddieH2020
EddieH2020 Oct. 17 at 2:54 PM
$PDSB I will buy 40-50k shares within the next 2-3 months after SLS explodes to lower my $6.83 cost basis. I will report back. Good luck all! cc: @Ontherag
3 · Reply
Test2025
Test2025 Oct. 17 at 12:07 PM
$PDSB the company sold more shares last night
1 · Reply
Aboutaam
Aboutaam Oct. 16 at 9:40 PM
$PDSB poppin off
0 · Reply
Mr_Charlie
Mr_Charlie Oct. 16 at 2:44 PM
$PDSB the new lads definetely don't know this stock.
0 · Reply
Stockman824
Stockman824 Oct. 16 at 2:03 PM
$PDSB good volume for the first half hour 175,000
0 · Reply
BuytheFear29
BuytheFear29 Oct. 16 at 1:47 PM
0 · Reply